Three-year evaluation of neuropsychiatric adverse events in the MONET trial of darunavir/ritonavir (DRV/r), with or without nucleoside analogues (NRTIs)

被引：0

作者：

Winston, A. ^{[1
]}

Arribas, J. ^{[2
]}

Hill, A. ^{[3
]}

van Delft, Y. ^{[4
]}

Moecklinghoff, C. ^{[5
]}

机构：

[1] St Marys Hosp, London, England

[2] Hosp La Paz, Madrid, Spain

[3] Univ Liverpool, Pharmacol Res Labs, Liverpool L69 3BX, Merseyside, England

[4] Janssen Cilag EMEA, Tilburg, Netherlands

[5] Janssen Cilag EMEA, Neuss, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：A65 / A65

页数：1